ArticleCNS drugs2022

Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.

Huixin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.